Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | USP2 | O75604 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1614306 | 0.82 | ALOX15 (0.58) | ALOX15ALDH1A1SMN1; SMN2CHRM5CHRM1 | |
| SCHEMBL17079536 | 0.81 | NAAA (0.40) | ALOX15ALDH1A1TDP1HPGDTSHR | |
| SCHEMBL7552905 | 0.81 | ALOX15 (0.70) | ALOX15ALDH1A1SMN1; SMN2CHRM5CHRM1 | |
| SCHEMBL12266939 | 0.79 | ALOX15 (0.59) | ALOX15ALDH1A1SMN1; SMN2CYP3A4HPGD | |
| SCHEMBL6135683 | 0.79 | ALOX15 (0.50) | ALOX15ALDH1A1TDP1SMN1; SMN2USP2 | |
| SCHEMBL6135686 | 0.79 | ALOX15 (0.50) | ALOX15ALDH1A1TDP1SMN1; SMN2USP2 | |
| SCHEMBL31538353 | 0.78 | ALOX15 (0.53) | ALOX15ALDH1A1TDP1SMN1; SMN2CYP3A4 | |
| SCHEMBL9506913 | 0.78 | ALOX15 (0.56) | ALOX15ALDH1A1SMN1; SMN2CHRM5CHRM1 | |
| SCHEMBL18663490 | 0.77 | ALOX15 (0.51) | ALOX15ALDH1A1TDP1SMN1; SMN2USP2 | |
| SCHEMBL10592155 | 0.75 | ALOX15 (0.58) | ALOX15ALDH1A1SMN1; SMN2CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3116848-B1 | PROCESS INVOLVING CROSS METATHESIS OF OLEFINS | GIVAUDAN SA (CH) | 2023-12-27 | — | — | EP | disclosed |
| CN-106103403-B | Process comprising cross metathesis of olefins | 奇华顿股份有限公司 | 2020-05-19 | — | — | CN | disclosed |
| US-20190100504-A1 | Process Involving Cross Metathesis of Olefins | GIVAUDAN S.A. (CH) | 2019-04-04 | — | — | US | disclosed |
| US-10144720-B2 | Process involving cross metathesis of olefins | GIVAUDAN S.A. (CH) | 2018-12-04 | — | — | US | disclosed |
| EP-3116848-A1 | PROCESS INVOLVING CROSS METATHESIS OF OLEFINS | Givaudan S.A. (CH) | 2017-01-18 | — | — | EP | disclosed |
| US-20160368888-A1 | Process Involving Cross Metathesis of Olefins | GIVAUDAN S.A. (CH) | 2016-12-22 | — | — | US | disclosed |
| WO-2015136093-A1 | PROCESS INVOLVING CROSS METATHESIS OF OLEFINS | GIVAUDAN SA (CH) | 2015-09-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10144720-B2 | Process involving cross metathesis of olefins | SYMPK, CLK1, MOK | ALOX15 1204/4885ALDH1A1 4255/4885TDP1 4095/4885 |
| US-20190100504-A1 | Process Involving Cross Metathesis of Olefins | SYMPK, CLK1, MOK | ALOX15 1204/4885ALDH1A1 4255/4885TDP1 4095/4885 |
| US-20160368888-A1 | Process Involving Cross Metathesis of Olefins | SYMPK, CLK1, MOK | ALOX15 1204/4885ALDH1A1 4255/4885TDP1 4095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.